Clinical trial
Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study
NCT06256575 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study
- Lead sponsor
- Primus Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 2, 2025
- Completion date
- August 15, 2027
- Enrollment
- 45 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
digital ulcer, scleroderma, systemic